---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-235413"
form_type: "8-K"
ticker: "BHC"
cik: "0000885590"
company_name: "Bausch Health Companies Inc."
filed_at: "2023-09-14T23:59:59+00:00"
generated_at: "2026-06-10T18:21:53.864145+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bausch + Lomb subsidiary prices $1.4B 8.375% senior secured notes due 2028

## Summary
- Bausch + Lomb subsidiary Bausch + Lomb Escrow Corp. priced $1.4B of 8.375% senior secured notes due 2028.
- Notes priced at 100% of principal; exempt from registration under Securities Act and Canadian securities laws.
- Proceeds expected to fund pending acquisition of XIIDRA and other ophthalmology assets.
- Offering is part of Bausch + Lomb's financing for the acquisition.

## SEC filing metadata
- accession: 0001193125-23-235413
- form_type: 8-K
- ticker: BHC
- cik: 0000885590
- company_name: Bausch Health Companies Inc.
- filed_at: 2023-09-14T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885590/000119312523235413/0001193125-23-235413-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885590/000119312523235413/d507768d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-235413
- JSON: https://secwatch.observer/filing/0001193125-23-235413.json
- Plain text: https://secwatch.observer/filing/0001193125-23-235413.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.